Sort
261,768 grants matching “gene therapy”
Inherited Ocular Diseases
$2,228,362James F. Hejtmancik · National Eye Institute · Z01 · FY2007 · EY
UC Irvine AD Translational Center for Disease Model Resources
$2,228,345Frank M Laferla · University Of California-Irvine · U54 · FY2018 · AG
Stem Cell Gene Therapy for Hemoglobinopathies
$2,228,313George Stamatoyannopoulos · University Of Washington · P01 · FY2008 · HL
Recombinant Adeno Associated Virus Vectors for Gene Transfer
$2,228,119Robert Kotin · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Skeletal Disorders and Mineral Homeostasis Section
$2,227,941Michael Collins · National Institute Of Dental & Craniofacial Research · ZIA · FY2022 · DE
Artificial Ecology Sink as prophylaxis against viral infection
$2,227,500Zhilei Chen · Texas A&M University Health Science Ctr · DP2 · FY2017 · AI
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
$2,227,276Robert C Bast · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA
Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder
$2,227,239Tariq M Rana · University Of California, San Diego · U01 · FY2025 · DA
Human Artificial Chromosomes for Cancer Research and Functional Genomics
$2,227,197Vladimir Larionov · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Epidemiology of Ovarian Cancer in African-American Women
$2,226,299Joellen M. Schildkraut · Duke University · R01 · FY2012 · CA
Elucidating Loci Involved in Prostate Cancer Suceptibility
$2,226,057Christopher Alan Haiman · University Of Southern California · U19 · FY2013 · CA
R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
$2,225,877James Wilson · University Of Pennsylvania · N01 · FY2014 · HL
Synaptic Vesicle Endocytosis
$2,225,755Ling Gang Wu · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Role of Sphingolipids in the Pathobiology of Lung Injury
$2,225,632Viswanathan Natarajan · University Of Illinois At Chicago · P01 · FY2013 · HL
Molecular Targeting of Developmental Cancers in Children
$2,225,598Sloan-Kettering Institute For Cancer Res · P01 · FY2005 · CA
A Gene therapeutic approach to stable suppression of HIV-1 replication
$2,225,513Michael R. Farzan · Harvard Medical School · P01 · FY2012 · AI
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
$2,225,217Barbara Burtness · Yale University · P50 · FY2023 · DE
Phase lll Study of the Effects of Selenium on Ademonas
$2,225,116M. Peter Lance · University Of Arizona · P01 · FY2009 · CA
Center for Multiple Myeloma Nanotherapy
$2,224,884Samuel Achilefu · Washington University · U54 · FY2017 · CA
Longitudinal Epigenomic Tracking of the Reprogramming Process
$2,224,182Michael P Snyder · Stanford University · P01 · FY2015 · GM
Genetic Epidemiology
$2,224,011Alisa Goldstein · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
iPSC Derived EC as Surrogates Using Pulmonary Hypertension as a Prototype Disease
$2,223,752Marlene Rabinovitch · Stanford University · U01 · FY2013 · HL
Stem Cell Gene Therapy for Hemoglobinopathies
$2,223,676George Stamatoyannopoulos · University Of Washington · P01 · FY2006 · HL
Mammalian Developmental Genetics and Stem Cells
$2,223,170Heiner Westphal · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
MIT Center for Integrative Synthetic Biology
$2,223,089Ron Weiss · Massachusetts Institute Of Technology · P50 · FY2017 · GM